COFCO Biotech's citric acid sales soar in 2022

On 27 April, COFCO Biotechnology Co., Ltd. (COFCO Biotech) issued its financial report for 2022 with drops in both revenue and new profit:Revenue: USD2,760.38 million, down by 15.46% YoYWhile citric acids and the derivatives raked in USD226.70 millio...

Acidity Regulator Quarterly China Report Q2 2023

www.cnchemicals.com